B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

GMNN

MOLECULAR TARGET

geminin DNA replication inhibitor

UniProt: O75496NCBI Gene: 5105358 compounds

GMNN (geminin DNA replication inhibitor) is targeted by 58 compounds in the BiohacksAI evidence corpus, derived from PubMed bioassay data. Each compound is ranked by confidence score (log-normalized assay count × evidence quality).

Compounds Targeting GMNN

Ranked by bioassay confidence score (PubChem active assay count × evidence quality).

#CompoundConfidenceActive Assays
1Disulfiram2.4010
2Colchicine2.087
3Rotenone2.087
42-Methoxyestradiol1.795
5Nocodazole Nocodazole is1.614
6Astemizole Antihistamine drug now withdrawn from1.393
7Metergoline1.393
8Podophyllotoxin1.393
9triflupromazine hydrochloride1.393
10Vorinostat1.393
11Calcimycin1.102
12Dasatinib1.102
13Digitoxin1.102
14Doxazosin1.102
15Ethinyl Estradiol1.102
16Hexachlorophene1.102
17kenpaullone1.102
18Niclosamide1.102
19Reserpine1.102
20Duloxetine Hydrochloride0.691
21Oleic Acid0.691
22ag4900.691
23Azacitidine0.691
24Azacitidine0.691
25Calcifediol0.691
26Calcitriol0.691
27Cholecalciferol Derivative of 7-dehydroxycholesterol formed by ULTRAVIOLET RAYS breaking of0.691
28cinacalcet0.691
29Clotrimazole0.691
30Decitabine0.691
31Desogestrel0.691
32Dibucaine0.691
33Digoxin0.691
34Ethylestrenol0.691
35Ethylmaleimide0.691
36Feprazone0.691
37Flunarizine Flunarizine is0.691
38Flunarizine Flunarizine is0.691
39Fluspirilene0.691
40gedunin0.691
41Idazoxan0.691
42Lanatosides Glycosides from DIGITALIS lanata leaf. Lanatoside C has actions similar to DIGOXIN. Mixtures of lanatosides A, B, and C have also been used. (From Martindale,0.691
43Loratadine0.691
44Methyldopa0.691
45Nisoldipine0.691
46Masoprocol0.691
47Ouabain0.691
48paxilline0.691
49Perphenazine0.691
50Quinestrol0.691

Showing top 50 of 58 compounds. Use the BiohacksAI search to explore all GMNN modulators.

About GMNN as a Drug Target

GMNN (geminin DNA replication inhibitor) is a well-characterized molecular target in biomedical research. BiohacksAI tracks 58 compounds with documented GMNN interaction from PubChem bioassay data, cross-referenced with PubMed clinical evidence. The confidence score reflects the log-normalized count of active PubChem assays, weighted by evidence quality from the BiohacksAI corpus.

GMNN inhibitors, activators, and modulators are of interest in research areas including longevity, metabolic health, and neurological function. Each compound profile includes evidence score, RCT count, human study ratio, research velocity, and domain relevance.